Difference between revisions of "Part:BBa K2309022:Experience"
Zixin.Rong (Talk | contribs) (Dot) |
Zixin.Rong (Talk | contribs) |
||
| (17 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
| − | |||
===Applications of BBa_K2309022=== | ===Applications of BBa_K2309022=== | ||
| − | This year we use dot blot method to evaluate part K2309022 work. | + | This year we use dot blot method to evaluate part K2309022 work. |
| − | https:// | + | |
| + | https://static.igem.org/mediawiki/parts/8/82/Dot_blot_for_LL-37_XJTLU-CHINA.jpeg | ||
| + | |||
| + | The picture shows the dot blotting result of produced LL-37 which induced by IPTG in BL21 strain. The left one shows the peptide LL-37 produced and right is non-induced BL21 by IPTG. | ||
| + | |||
| + | For LL-37 ability assay, we tested Minimal Inhibitory concentration(MIC) of <i>Staphylococcus aureus</i>, the result is shown as follows: | ||
| + | |||
| + | https://static.igem.org/mediawiki/parts/5/5c/LL-37_MIC_XJTLU-CHINA.jpeg | ||
| + | |||
| + | As picture shows that the concentration of LL-37 from 5ug/ml to 10ug/ml, the LL-37 has highly activities <i>Staphylococcus aureus</i>. | ||
| + | |||
| + | We also tested the anti-biofilm ability of LL-37 on biofilm formation of <i>Staphylococcus aureus</i>, the result as follows: | ||
| + | |||
| + | https://static.igem.org/mediawiki/parts/6/6c/LL-37_biofilm_XJTLU-CHINA.jpeg | ||
| + | |||
| + | The result shows that the value of Absorbance at 595nm decreases while the concentration of LL-37 increases. It seems that LL-37 peptide inhibits <i>Staphylococcus aureus</i> to form the biofilm. | ||
| + | |||
===User Reviews=== | ===User Reviews=== | ||
<!-- DON'T DELETE --><partinfo>BBa_K2309022 StartReviews</partinfo> | <!-- DON'T DELETE --><partinfo>BBa_K2309022 StartReviews</partinfo> | ||
| Line 13: | Line 28: | ||
|width='10%'| | |width='10%'| | ||
<partinfo>BBa_K2309022 AddReview number</partinfo> | <partinfo>BBa_K2309022 AddReview number</partinfo> | ||
| − | <I> | + | <I>XJTLU-CHINA</I> |
|width='60%' valign='top'| | |width='60%' valign='top'| | ||
Enter the review inofrmation here. | Enter the review inofrmation here. | ||
Latest revision as of 09:48, 1 November 2017
Applications of BBa_K2309022
This year we use dot blot method to evaluate part K2309022 work.
The picture shows the dot blotting result of produced LL-37 which induced by IPTG in BL21 strain. The left one shows the peptide LL-37 produced and right is non-induced BL21 by IPTG.
For LL-37 ability assay, we tested Minimal Inhibitory concentration(MIC) of Staphylococcus aureus, the result is shown as follows:
As picture shows that the concentration of LL-37 from 5ug/ml to 10ug/ml, the LL-37 has highly activities Staphylococcus aureus.
We also tested the anti-biofilm ability of LL-37 on biofilm formation of Staphylococcus aureus, the result as follows:
The result shows that the value of Absorbance at 595nm decreases while the concentration of LL-37 increases. It seems that LL-37 peptide inhibits Staphylococcus aureus to form the biofilm.
User Reviews
UNIQ29364bb186ed500b-partinfo-00000000-QINU UNIQ29364bb186ed500b-partinfo-00000001-QINU